Collagen-alpha-1(III)-chain Degradome Foundation Atlas

It is particularly abundant in tissues such as skin, blood vessels, gastrointestinal and respiratory tissues, and other organs requiring structural flexibility and tensile support. COL3A1 is also closely associated with vascular and connective-tissue biology, including disorders such as vascular Ehlers-Danlos syndrome. Characterizing the proteolytic fragment landscape of COL3A1 may therefore provide valuable insights into extracellular matrix remodeling, fibrosis, vascular and connective-tissue pathology, wound repair, and the development of peptide-based biomarkers.</p><h3 dir="ltr">Key Features of the Proteomics Dataset</h3><p dir="ltr">Using predicted enzymatic and chemical cleavage sites, the atlas systematically generates and annotates possible COL3A1 peptide fragments.

Each fragment is characterized using physicochemical features relevant to mass spectrometry, proteomics, and computational peptide analysis.</p><p dir="ltr"><b>Mass Spectrometry and Peptide Metrics:</b></p><ul><li>Molecular weight</li><li>Mass-to-charge ratio (m/z)</li><li>Net charge</li><li>Isoelectric point (pI)</li></ul><p dir="ltr"><b>Biochemical and Biophysical Features:</b></p><ul><li>Hydrophobicity</li><li>Boman index</li><li>Instability index</li><li>Aliphatic index</li></ul><p dir="ltr">Together, these annotations provide a feature-rich computational reference for exploring the detectability, physicochemical behaviour, and potential analytical relevance of COL3A1-derived peptides.</p><h3 dir="ltr">Applications in Biomarker Discovery and Biomedical Research</h3><p dir="ltr">The <b>Collagen Alpha-1(III) Chain Degradome Foundation Atlas</b> can support a broad range of experimental and computational applications, including:</p><ul><li><b>Targeted Proteomics:</b> Identification and prioritization of candidate COL3A1-derived peptides for mass-spectrometry assays.</li><li><b>Biomarker Discovery:</b> Exploration of collagen-derived peptide candidates associated with extracellular matrix remodeling, fibrosis, vascular disease, connective-tissue disorders, wound healing, and tissue injury.</li><li><b>Discovery Proteomics:</b> Interpretation and annotation of COL3A1-derived signals detected in mass-spectrometry datasets and biological fluids.</li><li><b>Degradomics:</b> Investigation of potential proteolytic processing patterns, collagenase and matrix metalloproteinase (MMP) cleavage footprints, and extracellular matrix-derived fragment populations.</li><li><b>Clinical Proteomics:</b> Computational exploration of Type III collagen turnover in physiological conditions and disease-associated matrix remodeling.</li><li><b>Connective-Tissue Research:</b> Investigation of COL3A1 processing in vascular biology and connective-tissue disorders, including conditions associated with pathogenic COL3A1 variants.</li><li><b>Computational Biology:</b> Generation of reference features for peptide-level modelling, degradome analysis, and machine-learning applications.</li><li><b>Assay Development:</b> Prioritization of candidate COL3A1 peptides for future experimental validation.</li></ul><h3 dir="ltr">Data Inclusion and Reproducibility</h3><p dir="ltr">The atlas provides a systematic computational representation of the <b>wild-type COL3A1 degradome</b>, including the complete set of theoretically generated contiguous peptide fragments and their calculated physicochemical properties.</p><p dir="ltr">Importantly, this Foundation Atlas represents a <b>theoretical fragment space rather than a catalogue of experimentally confirmed collagen peptides</b>.

Experimental proteomic and mass-spectrometry studies will be required to establish which predicted fragments are generated and detectable under physiological or disease-associated conditions.</p><p dir="ltr">Future releases will expand the resource through the incorporation of <b>disease-associated COL3A1 variants, post-translational and extracellular matrix modifications, experimentally validated cleavage products, and complementary experimental proteomics data</b>, progressively extending the atlas from a theoretical reference framework toward an experimentally informed representation of the COL3A1 degradome.</p>